Chemical Compound
ent-Paroxetine Hydrochloride
CAS Registry Number
130855-30-0
Primary Record
ent-Paroxetine Hydrochloride
- In stock
- 4,495 g
- Purity
- 99.3 %
- CAS
- 130855-30-0
Compound Identifiers & Properties
- CAS
- 130855-30-0
- PubChem CID
- 18635524
- SMILES
- C1CNC[C@@H]([C@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.Cl
- Canonical SMILES
- Cl.Fc1ccc([C@H]2CCNC[C@@H]2COc2ccc3c(c2)OCO3)cc1
Names & Synonyms
- ent-Paroxetine Hydrochloride
- Paroxetine Hcl
- Paroxetine impurity D
- 130855-30-0
- Paroxetine hydrochloride
- Paroxetine impurity D CRS
- C19H21ClFNO3
- E8A4U5DP45
- UNII-E8A4U5DP45
- Paroxetine hydrochloride, (+)-
- Paroxetine EP Impurity D HCl
- GELRVIPPMNMYGS-SATBOSKTSA-N
- SCHEMBL6100418
- (+)-trans-Paroxetine Hydrochloride
- DTXSID70595337
- Paroxetine hydrochloride, trans-(+)-
- MFCD22565990
- AKOS025401435
- Paroxetine EP Impurity D (HCl salt)
- EBC-170083
- FE22690
- NE16968
- AC-16421
- (3R,4S)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride
- Paroxetine impurity D CRS (Y0000256)
- DS-018346
- (3R,4S)-3-[(1,3-Benzodioxol-5-yloxy)me
- A11904
- EN300-115519
- H56876
- Paroxetine hydrochloride related compound C [USP-RS]
- (3R,4S)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;hydrochloride
- Z1489071220
- (3R-trans)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride
- PAROXETINE RELATED COMPOUND C (15 MG) ((+)-TRANS-PAROXETINE HYDROCHLORIDE)
- 78246-49-8
- (3R,4S)-3-((Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride
- (3R,4S)-3-[(2H-1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride
- (3R,4S)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride ((+)-trans-Paroxetine Hydrochloride)
- 130855-16-2
- (3R,4S)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidinehydrochloride
- (3R,4S)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine hydrochloride
- (3R,4S)-3-[(1,3-Benzodioxol-5-yloxy) methyl]-4-(4-fluorophenyl)piperidine hydrochloride
- (3R,4S)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride
- (3R,4S)-3-[(1,3-dioxaindan-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride
- trans-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride
- trans-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidinehydrochloride
- (3R,4S)-3-{[(2H-1,3-Benzodioxol-5-yl)oxy]methyl}-4-(4-fluorophenyl)piperidine--hydrogen chloride (1/1)
- Paroxetine Hydrochloride Anhydrous EP Impurity D; Paroxetine Hydrochloride EP Impurity D; Paroxetine Hydrochloride Hemihydrate EP Impurity D
- Paroxetine Hydrochloride Anhydrous Imp. D (EP); Paroxetine Imp. D (EP); Paroxetine USP Related Compound C; Paroxetine USP RC C; (3R,4S)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride; Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, (3R,4S)- (9CI); Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, (3R-trans)-; Paroxetine Related Compound C (USP); (+)-trans-Paroxetine Hydrochloride; BRL-29679A; USP Paroxetine Hydrochloride Related Compound C; Ph Eur Paroxetine Hydrochloride Impurity D; Paroxetine Related Compound C as Hydrochloride; Paroxetine Hydrochloride Hemihydrate Impurity D as Hydrochloride; Paroxetine Hydrochloride Impurity D as Hydrochloride; Paroxetine Impurity D as Hydrochloride; Paroxetine Impurity D as Hydrochloride